In a tweet, Wyden said his plan did not go far enough. His big speech on the issue pushed the stock prices of pharmaceutical companies higher.
The execs in pharmaceutical board rooms across the country are breathing a sigh of relief today – @realDonaldTrump still isn’t delivering on his promise to make prescription drugs more affordable.
— Ron Wyden (@RonWyden) May 11, 2018
.@realDonaldTrump‘s big drug speech sent pharmaceutical stocks through the roof – that’s an awfully bad sign for Americans with costly prescriptions. pic.twitter.com/r4QoiH9F60
— Ron Wyden (@RonWyden) May 11, 2018
